Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-6-14
pubmed:abstractText
Lamotrigine (LTG) is a commonly used antiepileptic drug. However, the use of LTG is limited because of its cutaneous adverse drug reactions (cADRs) ranging from mild maculopapular eruption (MPE) to severe Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). A strong association between HLA-B*1502 and carbamazepine-induced SJS/TEN has been identified in Chinese and Thai. Although three of seven cases with HLA-B*1502 have been reported in LTG-induced SJS/TEN so far, the relationship between HLA-B*1502 and LTG-induced SJS/TEN needs further investigation. It is also unclear whether there is a specific genetic marker associated with LTG-induced MPE in Chinese. In this study, we genotyped 43 Han Chinese patients treated with LTG (14 cases with LTG-induced cADRs and 29 LTG-tolerant controls), using PCR-SSP for HLA-B*1502 testing and low-resolution genotyping, as well as sequencing for four-digit genotyping. The two cases with SJS were negative for HLA-B*1502, with B1301/1301 and 4601/5610, respectively. Combining the data with previous studies, there was no significant difference in the frequency of subjects with HLA-B*1502 between the LTG-induced SJS/TEN group and the LTG-tolerant group (p?=?0.08, OR 4.23, 95% CI 0.94-18.97). In the MPE group, only one was positive for HLA-B*1502. There was no significant difference in the frequency of a specific HLA-B allele between the MPE group and the LTG-tolerant group either. In this study, no significant association between HLA-B*1502 and LTG-induced SJS or MPE was found. Given the small sample size and only HLA-B locus genotyping, further large-scale studies are required to explore genetic associations with LTG-induced cADRs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1742-7843
pubmed:author
pubmed:copyrightInfo
© 2011 The Authors. Basic & Clinical Pharmacology & Toxicology © 2011 Nordic Pharmacological Society.
pubmed:issnType
Electronic
pubmed:volume
109
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
42-6
pubmed:meshHeading
pubmed-meshheading:21306565-Adolescent, pubmed-meshheading:21306565-Aged, pubmed-meshheading:21306565-Alleles, pubmed-meshheading:21306565-Anticonvulsants, pubmed-meshheading:21306565-Asian Continental Ancestry Group, pubmed-meshheading:21306565-Base Sequence, pubmed-meshheading:21306565-Child, pubmed-meshheading:21306565-Child, Preschool, pubmed-meshheading:21306565-China, pubmed-meshheading:21306565-DNA Primers, pubmed-meshheading:21306565-Drug Eruptions, pubmed-meshheading:21306565-Female, pubmed-meshheading:21306565-Gene Frequency, pubmed-meshheading:21306565-Genotype, pubmed-meshheading:21306565-HLA-B Antigens, pubmed-meshheading:21306565-Humans, pubmed-meshheading:21306565-Male, pubmed-meshheading:21306565-Molecular Sequence Data, pubmed-meshheading:21306565-Polymerase Chain Reaction, pubmed-meshheading:21306565-Triazines, pubmed-meshheading:21306565-Young Adult
pubmed:year
2011
pubmed:articleTitle
Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.
pubmed:affiliation
Institute of Neuroscience and Second Affiliated Hospital of Guangzhou Medical University, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and Ministry of Education of China, Guangzhou, China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't